ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Also Cancer incidence, mortality level off after declines in 1990s.

September 12, 2003

How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director

November 19, 1999

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

Gleevec Decreases Recurrence Of Gastrointestinal Tumor

April 27, 2007